Clinical experience with retreatment for palliation.
Every radiation oncologist is faced occasionally with the need to consider reirradiation for palliation. Because reirradiation has the potential to exceed normal tissue tolerances, there is a need to have information on the efficacy and toxicity of retreatment. This article reviews the reirradiation literature and provides guidance to clinicians with regard to the risks, benefits, and side effects of retreatment.
Morris
D E
DE
Department of Radiation Oncology, the University of North Carolina, Chapel Hill, NC, USA.
D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy; D009369:Neoplasms / Q000532:radiotherapy*; D010166:Palliative Care; D011829:Radiation Dosage; D011832:Radiation Injuries; D019233:Retreatment; D018570:Risk Assessment